Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Refeyn announces appointment of Fiona Coats as Chief Marketing Officer Refeyn announces appointment of Fiona Coats as Chief Marketing Officer Fiona comes from Sartorius, and will drive the company's growth and solidify its market position Closed Loop Medicine appoints Paul Johnson as Non-Executive Director Closed Loop Medicine appoints Paul Johnson as Non-Executive Director Paul will work with the company to drive forward its commercialisation strategy for its portfolio of precision care solutions Sphere Fluidics appoints Curtis Nicholson as Director of Sales: EMEA Sphere Fluidics appoints Curtis Nicholson as Director of Sales: EMEA Curtis will lead the expansion of the company's sales and customer support activities Engitix appoints Matthew Edwards as SVP Discovery and Emma Huang as VP Data Sciences Engitix appoints Matthew Edwards as SVP Discovery and Emma Huang as VP Data Sciences The company welcomes the two novel appointments, who will assist in enhancing the drug discovery strategy Stablepharma welcomes Sir Jonathan Van-Tam to its advisory board Stablepharma welcomes Sir Jonathan Van-Tam to its advisory board The company will use Prof. Van-Tam's health expertise to advance its vaccination projects AlzeCure elect Dr Jan Lundberg as a new board member AlzeCure elect Dr Jan Lundberg as a new board member Dr Lundberg has experience in leadership position in global pharmaceutical companies, including AstraZeneca and Eli Lilly Enhanc3D Genomics appoints Hazel Jones as CEO Enhanc3D Genomics appoints Hazel Jones as CEO Hazel Jones has held previous roles in AstraZeneca and Cancer Research UK, and will drive operational change to advance disease diagnosis and treatments ERS Genomics appoints John E Milad as CEO ERS Genomics appoints John E Milad as CEO John brings more than 25 years of experience into the role, with a majority of his career being in the life sciences industry as a venture capitalist and investment banker John Patton, Head of Kindeva's Scientific Advisory Board, named winner of Charles G. Thiel award John Patton, Head of Kindeva's Scientific Advisory Board, named winner of Charles G. Thiel award RDD Conference’s Torbay Pharma strengthens leadership team to support North American growth strategy Torbay Pharma strengthens leadership team to support North American growth strategy The company has welcomed Mohammed Nazir as Chief Operating Officer (COO) and Tara Slivey as Chief Product Officer (CPO) Rentschler Biopharma appoints Patrick Cushing as VP Operations for US subsidiary Rentschler Biopharma appoints Patrick Cushing as VP Operations for US subsidiary The novel position will require Dr Cushing to manager operations at the Miford, MA facility in the US ProBioGen appoints Alfred Merz as CEO ProBioGen appoints Alfred Merz as CEO Dr Merz joins from Bayer Pharmaceuticals as CEO, focusing on developing the global reach of ProBioGen Sphere Fluidics appoints Dale Levitzke as CEO Sphere Fluidics appoints Dale Levitzke as CEO Dale Levitzke joins as Dr Frank F. Craig, current CEO and co-founder, announces his retirement Calluna Pharma appoints Margrethe Sørgaard as Senior Vice President of Clinical Operations and Pharmacovigilance Calluna Pharma appoints Margrethe Sørgaard as Senior Vice President of Clinical Operations and Pharmacovigilance First senior executive appointment made following company launch to oversee strategic development of clinical programmes Ascend hires Scott Law as COO Ascend hires Scott Law as COO He will join the company to optimise Ascend's operations from his recent role at Telix Pharmaceuticals as the Senior Vice President of Global Manufacturing and Operations Amarna Therapeutics appoints Aurelia Caparrós as new Chief Business Officer Amarna Therapeutics appoints Aurelia Caparrós as new Chief Business Officer Aurellia will be reponsible for driving Amarna's growth in the Netherlands and Spain Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer Denis will be responsible for optimising global operations for the company etherna appoints Shelly West as Business Development Director, US etherna appoints Shelly West as Business Development Director, US Shelly arrives from Cellpoint Biosciences and will be in charge of expanding etherna's US customer base Wacker Chemical Corporation promotes Christoph Kowitz to President of US subsidiary Wacker Chemical Corporation promotes Christoph Kowitz to President of US subsidiary The position originally held by David Willhoit is a promotion from Christoph's six year tenure as the Head of Corporate R&D Edward Rayner appointed as as Non-Executive Director of Sphere Fluidics Edward Rayner appointed as as Non-Executive Director of Sphere Fluidics Ed’s appointment will strengthen the company’s strategic vision as it progresses ambitious plans for future growth and commercial success KBI Biopharma appoints Jean-Baptiste Agnus as Chief Business Officer KBI Biopharma appoints Jean-Baptiste Agnus as Chief Business Officer Jean-Baptiste will bring more than 20 years' experience in the biopharmaceutical industry, and will aim to build and maintain KBI's long-term partnerships Cresset creates new Vice President role to lead its AI strategy Cresset creates new Vice President role to lead its AI strategy Dr Mutlu Dogruel joins from Microsoft, where he was responsible for empowering organisations to implement scalable AI solutions into their workflow Gerhard Schubert appoints Johannes Schubert as Head of Sales Gerhard Schubert appoints Johannes Schubert as Head of Sales Johannes Schubert follows on from Martin Sauter, who has relinquished the position for health reasons – though he remains with the company Veranova appoint Scott Lassonde as SVP, Chief Financial Officer Veranova appoint Scott Lassonde as SVP, Chief Financial Officer Scott has over 14 years of experience as a Chief Financial Officer in private manufacturing-based businesses
  • Previous
  • 1
  • …
  • 5
  • 6
  • 7
  • 8 (current)
  • 9
  • 10
  • 11
  • …
  • 142
  • Next

Trending Articles

  1. Saharsh Davuluri to take over as CEO & MD of Neuland and lead the next phase of CDMO expansion Announcement follows several years of stellar growth and points to a sharper focus on expanding commercial NCE opportunities
  2. FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organisation (CDMO) for biologics, vaccines, and advanced therapies, announced the appointment of Christiane Bardroff as Chief Business Officer (CBO), effective June 1, 2026
  3. Kindeva appoints Mike Cowhig as Chief Legal Officer The appointment will drive legal strategy, enterprise risk management and corporate governance across the organisation
  4. Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back The appointment of Susanne Back as Head of In Vivo Pharmacology will further strengthen its bioscience leadership and reinforcing its commitment to delivering high-quality, integrated drug discovery solutions for customers worldwide
  5. Germfree appoints Chief Executive Officer Carol Houts brings 30 years of healthcare and life sciences leadership to Germfree’s next phase of growth and execution

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK
See all

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.